Patent details

Basic Information

Publication number:

EP2301923

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101795565

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRIDINE DERIVATIVES AS DGAT INHIBITORS

French Title of Invention:

DÉRIVÉS DE PYRIDINE COMME INHIBITEURS DE DGAT

German Title of Invention:

PYRIDINDERIVATE ALS DGAT HEMMER

SPC Number:

Dates

Filing date:

28/03/2007

Grant date:

08/06/2016

EP Publication Date:

08/06/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/03/2011

EP B1 Publication Date:

08/06/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/03/2017

Expiration date:

28/03/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/03/2007

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Serrano-Wu Michael H.

Address:

United States (US)

2

Name:

Liu Wenming

Address:

United States (US)

3

Name:

Kwak Young-Shin

Address:

United States (US)

Priority

Priority Number:

787859 P

Priority Date:

31/03/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 213/74;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages